Search for molecules which bind to SCC antigen, analysis of their functions and clinical significance, and application to the molecular target therapy
寻找SCC抗原结合分子,分析其功能和临床意义,及其在分子靶向治疗中的应用
基本信息
- 批准号:20591950
- 负责人:
- 金额:$ 3.16万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2008
- 资助国家:日本
- 起止时间:2008 至 2010
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The SCC antigen binds to the protein, which was identified to be carbonyl reductase (CR). The immunostaining analyses revealed that CR is located in the cytoplasm of keratinocytes and the normal squamous epithelial cells of the uterine cervix as well as SCCA1 and SCCA2. Sense and antisense CR cDNAs were transfected into a human uterine SCC cell lines to investigate the role of CR in cancer cell invasion and metastasis. In an in vitro experiment, suppression of CR showed morphology changes to like fibroblast, increased cancer cell invasion, secretion of MMP. On the other hand, over-expression of CR decreased MMP secretion. Paraffin sections from uterine cervical SCC tissues, FIGO stage Ib1-IIb were immunostained with anti-CR antibodies. Overall survival (OS) and progression-free survival (PFS) were analyzed by the Kaplan-Meier method. Immunohistochemical analyses showed that reduced CR expression patterns in primary cancer lesions were closely associated with a high incidence of pelvic lymph node metastasis, poor OS, and poor PFS.
SCC抗原结合到蛋白质上,该蛋白质被鉴定为羰基还原酶(CR)。免疫组化结果显示,CR定位于角质形成细胞和正常宫颈鳞状上皮细胞以及SCCA 1和SCCA 2的细胞质中。将正义和反义CR cDNA转染人子宫鳞癌细胞系,研究CR在癌细胞侵袭和转移中的作用。在体外实验中,CR的抑制表现为形态学变化,类似成纤维细胞,癌细胞侵袭增加,MMP分泌增加。另一方面,CR的过度表达降低MMP的分泌。用抗CR抗体对FIGO Ib 1-IIb期宫颈SCC组织的石蜡切片进行免疫染色。采用Kaplan-Meier法分析总生存期(OS)和无进展生存期(PFS)。免疫组化分析显示,原发癌病灶中CR表达模式降低与盆腔淋巴结转移发生率高、OS差和PFS差密切相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SCC抗原の結合分子carbonyl reductaseの機能解析と子宮頸部扁平上皮癌における臨床意義の解明
SCC抗原结合分子羰基还原酶的功能分析及其在宫颈鳞癌中的临床意义
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Li L;Tanaka T;Yukawa K;Akira S;Umesaki N;苛原稔;Yoneyama K.;村上明弘
- 通讯作者:村上明弘
Carbonyl reductase, a binding molecule to SCC antigen
羰基还原酶,SCC 抗原的结合分子
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Fukushima C;Murakami A
- 通讯作者:Murakami A
Comparative proteomic profiling in squamous cell carcinoma of the uterine cervix
- DOI:10.1002/prca.201000077
- 发表时间:2011-04-01
- 期刊:
- 影响因子:2
- 作者:Fukushima, Chikako;Murakami, Akihiro;Sugino, Norihiro
- 通讯作者:Sugino, Norihiro
Identification and analysis of the intracellular molecules bound to SCC antigen.
与 SCC 抗原结合的细胞内分子的鉴定和分析。
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Kajihara H;Yamada Y;Kanayama S;Furukawa N;Noguchi T;Haruta S;Yoshida S;Sado T;Oi H;Kobayashi H.;Nagai Y.;村上明弘
- 通讯作者:村上明弘
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MURAKAMI Akihiro其他文献
MURAKAMI Akihiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MURAKAMI Akihiro', 18)}}的其他基金
Strategy to treatment of uterine sarcoma inducing of mesenchymal to epithelial transition
诱导间质向上皮转化的子宫肉瘤的治疗策略
- 批准号:
26462525 - 财政年份:2014
- 资助金额:
$ 3.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of carbonyl reductase function -development of the new molecular target therapy-
羰基还原酶功能分析-新型分子靶向治疗的开发-
- 批准号:
23592452 - 财政年份:2011
- 资助金额:
$ 3.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




